ZA901630B - Use of a naphthalenmethanamino derivative as anti-inflammatory agent and pharmaceutical compositions containing it - Google Patents

Use of a naphthalenmethanamino derivative as anti-inflammatory agent and pharmaceutical compositions containing it

Info

Publication number
ZA901630B
ZA901630B ZA901630A ZA901630A ZA901630B ZA 901630 B ZA901630 B ZA 901630B ZA 901630 A ZA901630 A ZA 901630A ZA 901630 A ZA901630 A ZA 901630A ZA 901630 B ZA901630 B ZA 901630B
Authority
ZA
South Africa
Prior art keywords
naphthalenmethanamino
derivative
pharmaceutical compositions
compositions containing
inflammatory agent
Prior art date
Application number
ZA901630A
Other languages
English (en)
Inventor
Philip Henry Cooper
Henry Cooper Philip
Hubert Mieth
Mieth Hubert
Ingeborg Schuster
Schuster Ingeborg
Anton Stuetz
Stuetz Anton
Friedrich Richter
Richter Friedrich
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA901630B publication Critical patent/ZA901630B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/16Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings
    • C07C211/19Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings containing condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA901630A 1989-03-03 1990-03-02 Use of a naphthalenmethanamino derivative as anti-inflammatory agent and pharmaceutical compositions containing it ZA901630B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3906720 1989-03-03

Publications (1)

Publication Number Publication Date
ZA901630B true ZA901630B (en) 1991-11-27

Family

ID=6375385

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA901630A ZA901630B (en) 1989-03-03 1990-03-02 Use of a naphthalenmethanamino derivative as anti-inflammatory agent and pharmaceutical compositions containing it

Country Status (11)

Country Link
EP (1) EP0385952A2 (xx)
JP (1) JPH0334959A (xx)
KR (1) KR900014305A (xx)
AU (1) AU5060190A (xx)
CA (1) CA2011247A1 (xx)
FI (1) FI901057A0 (xx)
HU (1) HUT58201A (xx)
IL (1) IL93590A0 (xx)
NO (1) NO900972L (xx)
PT (1) PT93306A (xx)
ZA (1) ZA901630B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
WO1997008133A1 (en) 1995-08-22 1997-03-06 Japan Tobacco Inc. Amide compounds and use of the same
JP4029960B2 (ja) * 2001-10-05 2008-01-09 独立行政法人理化学研究所 アブシジン酸生合成阻害剤
BRPI0418589A (pt) 2003-12-08 2008-01-29 Bentley Pharmaceuticals Inc composições farmacêuticas e métodos para tratamento por insulina

Also Published As

Publication number Publication date
IL93590A0 (en) 1990-12-23
HU901189D0 (en) 1990-05-28
HUT58201A (en) 1992-02-28
KR900014305A (ko) 1990-10-23
CA2011247A1 (en) 1990-09-03
PT93306A (pt) 1990-11-07
AU5060190A (en) 1990-09-06
NO900972L (no) 1990-09-04
EP0385952A2 (en) 1990-09-05
JPH0334959A (ja) 1991-02-14
FI901057A0 (fi) 1990-03-01
NO900972D0 (no) 1990-03-01

Similar Documents

Publication Publication Date Title
NZ233320A (en) 3-substituted-2-oxo-indole derivatives and pharmaceutical compositions
NZ238545A (en) Dialkoxy-pyridinyl-benzimidazole derivatives; preparation and pharmaceutical compositions thereof
IL103932A0 (en) Fatty acid derivatives and pharmaceutical compositions containing them
HU900583D0 (en) Lasting dissolving of pharmaceutical compositions
IL112558A (en) Neuroprotective pharmaceutical compositions of 4 phenylpinene derivatives and certain novel 4 phenylpinene compounds
IL108019A0 (en) Hydroxyiminoalkylindole-carboxylic acid derivatives their preparation and pharmaceutical compositions containing them
IL115072A0 (en) Substituted 4-phenyl-6-amino-nicotinic acid derivatives their preparation pharmaceutical compositions containing them and their use
NZ233790A (en) Benzocycloalkane derivatives and pharmaceutical compositions
HU896612D0 (en) Process for the preparation of 2-iminebenzothiazole derivatives and pharmaceutical compositions thereof
HU896479D0 (en) Process for the preparation of capsaycin derivatives and pharmaceutical compositions thereof
IL96747A0 (en) Oxazole derivatives and pharmaceutical compositions containing them
NZ236483A (en) Glycerol derivatives and pharmaceutical compositions thereof
ZA948689B (en) New taxicin derivatives their preparation and pharmaceutical compositions containing them
IL98198A0 (en) Pharmaceutical compositions containing a derivative of substituted-l-valyl-l-prolinamide
NZ232701A (en) Substituted benzoxazolinone derivatives and pharmaceutical compositions
NZ233013A (en) Substituted thieno-triazolo-diazepine derivatives and pharmaceutical compositions
ZA901630B (en) Use of a naphthalenmethanamino derivative as anti-inflammatory agent and pharmaceutical compositions containing it
IL89155A0 (en) Ouabain-like compounds and pharmaceutical compositions containing them
HU895948D0 (en) Process for the preparation of dipeptidecarbamide derivatives having inhibition of renine and pharmaceutical compositions thereof
ZA933426B (en) New dihydroxybenzylamine derivatives their preparation and pharmaceutical compositions which contain them
HU896636D0 (en) Process for the preparation of polyhydroxy-benzyloxypropanolamines and pharmaceutical compositions thereof
HU9302821D0 (en) Pharmaceutical compositions containing 3-substituted-2-oxindole-1-carboxamide as medical agent
NZ234803A (en) Oxazolopyridine derivatives and analgesic pharmaceutical compositions
GB9304745D0 (en) Use of pharmaceutical formulations
IL108881A0 (en) Pharmaceutical compositions containing a combination of verapamil and trandolapril